UPDATE: UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell
(Updated - November 11, 2022 7:55 AM EST)
UBS analyst Michael Leuchten downgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
UBS analyst Michael Leuchten downgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)